These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3327976)

  • 1. [Fundamental studies and reference values of cancer associated antigen NCC-ST-439].
    Yoshioka H; Sakurabayashi I; Kawai T; Suzuki M
    Rinsho Byori; 1987 Nov; 35(11):1233-8. PubMed ID: 3327976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basic studies and the reference values of cancer associated antigen CA-50].
    Yoshioka H; Shitara M; Sakurabayashi I; Kawai T; Suzuki M
    Rinsho Byori; 1988 Feb; 36(2):171-6. PubMed ID: 3288785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental studies and the reference values of cancer associated antigen TAG-72 (CA72-4)].
    Shitara M; Yoshioka H; Sakurabayashi I; Kawai T; Suzuki M
    Rinsho Byori; 1988 Oct; 36(10):1177-81. PubMed ID: 3246730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023)].
    Sakurabayashi I; Kawai T; Omizo R; Hattori N; Ishii M
    Rinsho Byori; 1988 Dec; 36(12):1407-12. PubMed ID: 2854864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer].
    Kamachi S; Sakurabayashi I; Kawai T
    Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers in gastrointestinal cancer].
    Shimano T; Monden T; Oji Y; Morimoto H; Tomita N; Mori T
    Rinsho Byori; 1985 Aug; 33(8):853-60. PubMed ID: 3908746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of a pancreatic cancer-associated glycoprotein antigen, DU-PAN-2. I. Enzymeimmunoassay and distribution of serum values in healthy persons].
    Sakurabayashi I; Yamada T; Kawai T; Yamanaka T
    Rinsho Byori; 1986 Jun; 34(6):705-10. PubMed ID: 3528587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M
    Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of CA 19-9 radioimmunoassay].
    Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NCC-ST-439].
    Sugano K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
    Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
    Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fundamental studies and the reference values of basic fetoprotein].
    Shitara M; Yoshioka H; Sakurabayashi I; Kawai T
    Rinsho Byori; 1988 Sep; 36(9):1039-44. PubMed ID: 3073231
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardization and quality control of tumour marker assays.
    Ward AM
    Dis Markers; 1991; 9(3-4):127-32. PubMed ID: 1813205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basic and clinical studies on serum CEA levels using a new CEA-EIA (double monoclonal) kit].
    Ogoshi K; Mitomi T
    Gan No Rinsho; 1984 Dec; 30(15):1913-8. PubMed ID: 6396422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental studies of measurement of serum tissue polypeptide antigen (TPA) using TPA RIA kit Prolifigen].
    Endo K; Sakahara H; Nakajima K; Nakajima T; Ohta H; Torizuka K
    Kaku Igaku; 1984 Jan; 21(1):75-81. PubMed ID: 6737794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Normal blood ferritin values determined by 6 commercial kits. French Society of Clinical Biology].
    Ann Biol Clin (Paris); 1983; 41(6):453-8. PubMed ID: 6364901
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.